Resveratrol mitigates hepatic injury in rats by regulating oxidative stress, nuclear factor-kappa B, and apoptosis

• Published in: Journal of advanced pharmaceutical technology and research 2016-07, Vol.7 (3), p.99-104
• Main Authors: Seif el.Din, Sayed, El-Lakkany, Naglaa, Salem, Maha, Hammam, Olfat, Saleh, Samira, Botros, Sanaa
• Format: Article
• Language: English
• Subjects: Alanine; Antidiabetics; Antioxidants; Antioxidants (Nutrients); Apoptosis; Caspase; Caspase-3; Cytokines; cytotoxicity; Data processing; Degeneration; Diabetes mellitus; Drug dosages; Experiments; Glutathione; Hepatocytes; Histochemistry; Inflammation; Injuries; Interleukin 6; Liver; Liver diseases; liver inflammation; Malondialdehyde; Metastases; NF-κB protein; Original; Oxidative stress; Pain perception; pro-inflammatory cytokines; Resveratrol; Silymarin; Superoxide dismutase; Thioacetamide; Tumor necrosis factor-TNF; Tumor necrosis factor-α; γ-Interferon
• ISSN: 2231-4040; 0976-2094
• DOI: 10.4103/2231-4040.184594

Resveratrol is a naturally occurring polyphenol, possesses several pharmacological activities including anticancer, antioxidant, antidiabetic, antinociceptive, and antiasthmatic activity. Little is known about its hepatoprotective action mechanisms. This study was conceived to explore the possible protective mechanisms of resveratrol compared with the hepatoprotective silymarin in thioacetamide (TAA)-induced hepatic injury in rats. Thirty-two rats were equally divided into four groups; normal control (i), TAA (100 mg/kg) (ii), TAA + silymarin (50 mg/kg) (iii), and TAA + resveratrol (10 mg/kg) (iv). Liver function and histopathology, pro-inflammatory cytokines, oxidative stress, and apoptotic markers were examined. Data were analyzed using ANOVA test followed by Tukey post hoc test. Compared to TAA-intoxicated group, resveratrol mitigated liver damage, and inflammation as noted by less inflammatory infiltration, hydropic degeneration with decreased levels of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma by 78.83, 18.12, and 64.49%, respectively. Furthermore, it reduced (P < 0.05) alanine and aspartate aminotransferases by 36.64 and 48.09%, respectively, restored hepatic glutathione content and normalized superoxide dismutase and malondialdehyde levels. While it inhibited nuclear factor-kappa B, cytochrome 2E1, and enhanced apoptosis of necrotic hepatocytes via increasing caspase-3 activity. Our findings indicated that the potential hepatoprotective mechanisms of resveratrol are associated with inhibition of inflammation, enhancing the apoptosis of necrotic hepatocytes, and suppression of oxidative stress.